Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malgorzata Stec

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|August 4, 2019
CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not?Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, et al.
Molecules (Basel, Switzerland)|May 7, 2025
Correction: Musielak et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? <i>Molecules</i> 2019, <i>24</i>, 2804Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for ImmunotherapyAlicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol, et al.
Cancers|December 11, 2022
Improving the Effect of Cancer Cells Irradiation with X-rays and High-Energy Protons Using Bimetallic Palladium-Platinum Nanoparticles with Various NanostructuresBartosz Klebowski, Malgorzata Stec, Joanna Depciuch, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
N-methylmorpholine incorporation into the structure of biphenyl leads to the bioactive inhibitor of PD-1/PD-L1 interactionJulia Zaber, Lukasz Skalniak, Ganna P Gudz, et al.
RSC Advances|May 6, 2022
Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Au nanoparticles for MRI-guided chemo/NIR photothermal therapy of cancer cellsAlexey Maximenko, Joanna Depciuch, Natalia Łopuszyńska, et al.
Journal of Medicinal Chemistry|September 16, 2020
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune CheckpointMagdalena Konieczny, Bogdan Musielak, Justyna Kocik, et al.
Molecular Cancer|September 7, 2023
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodiesIsmael Rodriguez, Justyna Kocik-Krol, Lukasz Skalniak, et al.
Journal of Medicinal Chemistry|July 27, 2021
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein InteractionDamian Muszak, Ewa Surmiak, Jacek Plewka, et al.
European Journal of Medicinal Chemistry|February 15, 2026
N-terphenylpicolinamide derivatives designed to target PD-L1 increase activation and proliferation of T cells, and their cytotoxic properties toward cancer cellsDamian Muszak, Justyna Kocik-Krol, Julia Zaber, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Molecules (Basel, Switzerland)|August 4, 2019
CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not?Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, et al.
Molecules (Basel, Switzerland)|May 7, 2025
Correction: Musielak et al. CA-170 - A Potent Small-Molecule PD-L1 Inhibitor or Not? <i>Molecules</i> 2019, <i>24</i>, 2804Bogdan Musielak, Justyna Kocik, Lukasz Skalniak, et al.
ACS Medicinal Chemistry Letters|July 16, 2025
Characterization of Clinically Evaluated Small-Molecule Inhibitors of PD-L1 for ImmunotherapyAlicja Slota, Katarzyna Golebiowska-Mendroch, Justyna Kocik-Krol, et al.
Cancers|December 11, 2022
Improving the Effect of Cancer Cells Irradiation with X-rays and High-Energy Protons Using Bimetallic Palladium-Platinum Nanoparticles with Various NanostructuresBartosz Klebowski, Malgorzata Stec, Joanna Depciuch, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2024
N-methylmorpholine incorporation into the structure of biphenyl leads to the bioactive inhibitor of PD-1/PD-L1 interactionJulia Zaber, Lukasz Skalniak, Ganna P Gudz, et al.
RSC Advances|May 6, 2022
Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Au nanoparticles for MRI-guided chemo/NIR photothermal therapy of cancer cellsAlexey Maximenko, Joanna Depciuch, Natalia Łopuszyńska, et al.
Journal of Medicinal Chemistry|September 16, 2020
Di-bromo-Based Small-Molecule Inhibitors of the PD-1/PD-L1 Immune CheckpointMagdalena Konieczny, Bogdan Musielak, Justyna Kocik, et al.
Molecular Cancer|September 7, 2023
Structural and biological characterization of pAC65, a macrocyclic peptide that blocks PD-L1 with equivalent potency to the FDA-approved antibodiesIsmael Rodriguez, Justyna Kocik-Krol, Lukasz Skalniak, et al.
Journal of Medicinal Chemistry|July 27, 2021
Terphenyl-Based Small-Molecule Inhibitors of Programmed Cell Death-1/Programmed Death-Ligand 1 Protein-Protein InteractionDamian Muszak, Ewa Surmiak, Jacek Plewka, et al.
European Journal of Medicinal Chemistry|February 15, 2026
N-terphenylpicolinamide derivatives designed to target PD-L1 increase activation and proliferation of T cells, and their cytotoxic properties toward cancer cellsDamian Muszak, Justyna Kocik-Krol, Julia Zaber, et al.
Pageof 2